(Q33145120)

22 July 2017

1 reference

title

Putting it together: a new treatment algorithm for vasovagal syncope and related disorders (English)

1 reference

22 July 2017

0 references

0 references

3

0 references

Robert Stanley Sheldon

2

0 references

author name string

Bloomfield DM

1

1 reference

22 July 2017

Calkins H

4

1 reference

22 July 2017

Sutton R

5

1 reference

22 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

American Journal of Cardiology

22 July 2017

published in

1 reference

22 July 2017

volume

84

1 reference

22 July 2017

issue

8A

1 reference

22 July 2017

page(s)

33Q-39Q

1 reference

Midodrine: a role in the management of neurocardiogenic syncope.

22 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Randomized, double-blind, placebo-controlled trial of oral enalapril in patients with neurally mediated syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Clinical disorders of the autonomic nervous system associated with orthostatic intolerance: an overview of classification, clinical evaluation, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Neurally mediated syncopal syndromes: pathophysiological concepts and clinical evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

The economics of treating vasovagal syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Pathophysiology and differential diagnosis of neurocardiogenic syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Effects of age on outcome of tilt-table testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Methodology of head-up tilt testing in patients with unexplained syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Increased activity in left ventricular receptors during hemorrhage or occlusion of caval veins in the cat. A possible cause of the vaso-vagal reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Impairment of physical and psychosocial function in recurrent syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Recurrence of neurocardiogenic syncope without pharmacologic interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Timing of first recurrence of syncope predicts syncopal frequency after a positive tilt table test result

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

A controlled trial of acute and long-term medical therapy in tilt-induced neurolly mediated syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Pharmacologic approaches to therapy for vasovagal syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

The postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during head-up tilt table testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Chronic orthostatic intolerance: part of a spectrum of dysfunction in orthostatic cardiovascular homeostasis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

7 January 2021

Idiopathic hypovolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

The orthostatic tachycardia syndrome: evaluation of autonomic function and treatment with octreotide and ergot alkaloids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Tilt table testing for assessing syncope. American College of Cardiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Indications, methodology, and classification of results of tilt-table testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Role of pacing in the treatment of vasovagal syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

Head-up tilt: a useful test for investigating unexplained syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900694-3

10.1016/S0002-9149(99)00694-3

7 January 2021

Identifiers

DOI

1 reference

22 July 2017

1 reference